TrialJournal of neuro-oncology2015

Hypofractionated-intensity modulated radiotherapy (hypo-IMRT) and temozolomide (TMZ) with or without bevacizumab (BEV) for newly diagnosed glioblastoma multiforme (GBM): a comparison of two prospective phase II trials.

Julie A Carlson et al.PubMed ↗Publisher ↗

No numbers read from the abstract.